You are here: All Products  > Evopoint to Start China Trial of EZH2 Inhibitor Combined with Merck/MSD’s Keytruda

Evopoint to Start China Trial of EZH2 Inhibitor Combined with Merck/MSD’s Keytruda

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products